Docetaxel Injection, Solution
Product Images NDC 43598-611

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Docetaxel (NDC 43598-611). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

4carton (4carton)

Packaging label for Docetaxel Injection USP 80 mg/4 mL (20 mg/mL) single use vial by Dr. Reddy's Laboratories Inc. The carton states it is a new concentration and preparation, ready to add to infusion solution for intravenous infusion only. The label includes storage instructions, usage warnings, and manufacturer information from Dr. Reddy's Laboratories Limited, Visakhapatnam, India.*

FDA Label Image

4vial (4vial)

Label for Docetaxel Injection USP 80 mg/4 mL (20 mg/mL) intravenous infusion solution. The label indicates a one-vial formulation, cytotoxic agent status, and directions to add to infusion solution. It includes manufacturer details: Dr. Reddy's Laboratories Limited, India. The label features a barcode and branding for Novaplus.*

FDA Label Image

Box (Box)

This image displays text instructions for oral corticosteroid dosing associated with docetaxel injection. It includes schedules for patients receiving docetaxel every three weeks for breast, non-small cell lung, stomach, head and neck cancers, and prostate cancer. The text outlines specific days and times to take corticosteroids relative to docetaxel injection treatment days.*

FDA Label Image

Carton (Carton)

Packaging label for Docetaxel Injection USP 20 mg/mL, 1 mL single-use vial. The label specifies the product as a ready-to-add one-vial formulation for intravenous infusion only, manufactured by Dr. Reddy's Laboratories Inc. It includes usage warnings to not use the two-vial formulation with the one-vial formulation and storage instructions. The label also features the Novaplus trademark and barcodes on the packaging.*

FDA Label Image

Fig1 (Fig1)

A line graph showing disease-free survival probability over time in months for two groups labeled TAC and FAC. The y-axis represents disease-free survival probability in percentage, and the x-axis shows disease-free survival time in months. Both lines decline over time with the TAC group maintaining a higher survival probability.*

FDA Label Image

Fig10 (Fig10)

A survival probability plot showing overall survival over time in months for two patient groups: TPF (n=255) and PF (n=246). The vertical axis represents survival probability in percentage, ranging from 0% to 100%, and the horizontal axis represents survival time in months, spanning 0 to 72 months. The graph includes a table below indicating the number of patients at risk at various time intervals for each group.*

FDA Label Image

Fig2 (Fig2)

A survival probability plot showing two treatment groups labeled TAC and FAC over a survival time measured in months. The vertical axis represents survival probability percentage, while the horizontal axis shows survival time from 0 to about 66 months. The TAC group has a slightly higher survival probability curve compared to the FAC group throughout most of the time period.*

FDA Label Image

Fig3 (Fig3)

A Kaplan-Meier survival curve chart showing overall survival probability over time in months. The chart compares two groups labeled T75 and BSC, with the y-axis representing cumulative probability and the x-axis showing survival time in months. A p-value from the log-rank test is indicated as 0.010.*

FDA Label Image

Fig4 (Fig4)

A Kaplan-Meier survival curve chart showing overall survival probability over time in months. Two survival curves are compared, labeled T75 and V/I, with cumulative probability on the vertical axis and survival time in months on the horizontal axis. The chart includes a log-rank p value of 0.13 indicating comparison between groups.*

FDA Label Image

Fig5 (Fig5)

A survival probability curve chart displaying survival time in months on the x-axis and survival probability on the y-axis. The chart compares two groups labeled "T75 q3w" and "M q3w" with corresponding survival trends over a 30-month period.*

FDA Label Image

Fig6 (Fig6)

A survival curve chart showing probability (%) over time (months) for two groups labeled TCF and CF, illustrating their respective decline in probability over a 24-month period.*

FDA Label Image

Fig7 (Fig7)

A survival curve graph depicting survival probability (%) over time in months. The graph shows two lines labeled TCF and CF, illustrating the change in survival probability for each group across a 0 to 36 month period.*

FDA Label Image

Fig8 (Fig8)

A Kaplan-Meier survival curve chart showing Progression Free Survival (PFS) probability over time in months. The graph compares two groups labeled TPF and PF, with PFS probability (%) on the vertical axis and progression free survival time (months) on the horizontal axis, illustrating survival differences between the two groups.*

FDA Label Image

Fig9 (Fig9)

A Kaplan-Meier survival curve chart comparing survival probability (%) over survival time (months) for two treatment groups labeled TPF and PF. The graph shows survival rates declining over time for both groups, with TPF consistently showing higher survival probabilities than PF throughout the duration.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Docetaxel, showing its detailed molecular framework as represented in the image.*

FDA Label Image

Vial (Vial)

Label for Docetaxel Injection USP 20 mg/mL, an intravenous infusion solution by Dr. Reddy's Laboratories Inc. The label states it is a one-vial formulation, ready to add to infusion solution, and identifies the product as a cytotoxic agent. It includes dosage strength, usage instructions, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.